Case study: Purification of Group C meningococcal polysaccharide for a conjugate vaccine

R&D is a staple of the vaccine industry. Each new discovery is another step towards the global eradiation of another disease. Shwu-Maan Lee, Director, Technical Affairs, Baxter BioScience joined us at the World Vaccine Congress in Washington 2012 to give details on the Group c meningococcal polysaccharide for a conjugate vaccine. In 2000, the NeisVac-C was licensed in 38 countries …